PIMSTONE SIMON N. (CEO) sold 3.0% of their position (8K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $113.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/2/2020ACC: 0001209191-20-033578
DirectorOfficer· CEO
Since Sep 2019
-8K
Net shares
Net seller
$113.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
−5K
Price / share
$13.99
Trade value
$69.95K
% of position
1.9%
5/29/2020
263.19K→258.19K
Common Shares
Direct
Shares
−3K
Price / share
$14.43
Trade value
$43.29K
% of position
1.2%
6/1/2020
258.19K→255.19K
Total
Net shares
−8K
Net value
-$113.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 5/29/2020 | S · Sale | −5K | $13.99 | $69.95K | 1.9% | 263.19K | 258.19K |
| Common Shares Direct | 6/1/2020 | S · Sale | −3K | $14.43 | $43.29K | 1.2% | 258.19K | 255.19K |
| Total | −8K | -$113.24K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned16.46K
Total
16.46K indirect16.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 16.46K | Indirect |
| Total | 16.46K | 16.46K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported